Lactosylceramide (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lactosylceramide" in English language version.

refsWebsite

Global rank English rank

4^th place

2^nd place

low place

1^st place

low place

11^th place

8^th place

doi.org

Barth BM, Shanmugavelandy SS, Tacelosky DM, Kester M, Morad SA, Cabot MC (1 January 2014). "Gaucher's disease and cancer: a sphingolipid perspective". Critical Reviews in Oncogenesis. 18 (3): 221–234. doi:10.1615/critrevoncog.2013005814. PMC 3604879. PMID 23510065.
Pandey MK, Burrow TA, Rani R, Martin LJ, Witte D, Setchell KD, et al. (March 2017). "Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease". Nature. 543 (7643): 108–112. doi:10.1038/nature21368. PMID 28225753. S2CID 4040507.

"Showing metabocard for Lactosylceramide (d18:1/12:0) (HMDB0004866)". Human Metablome Database (HMDB). 2005-04-30. Retrieved 23 May 2019.

Christie WW (10 January 2019). "Lactosylceramide and non-Acidic Oligoglycosylceramides". The LipidHome. Archived from the original on 9 August 2016. Retrieved 13 July 2019.

Barth BM, Shanmugavelandy SS, Tacelosky DM, Kester M, Morad SA, Cabot MC (1 January 2014). "Gaucher's disease and cancer: a sphingolipid perspective". Critical Reviews in Oncogenesis. 18 (3): 221–234. doi:10.1615/critrevoncog.2013005814. PMC 3604879. PMID 23510065.
Pandey MK, Burrow TA, Rani R, Martin LJ, Witte D, Setchell KD, et al. (March 2017). "Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease". Nature. 543 (7643): 108–112. doi:10.1038/nature21368. PMID 28225753. S2CID 4040507.

"Lactosylceramide (d18:1/12:0)". PubChem Compound Database. National Center for Biotechnology Information, U.S. National Library of Medicine. Retrieved 13 July 2019.

Barth BM, Shanmugavelandy SS, Tacelosky DM, Kester M, Morad SA, Cabot MC (1 January 2014). "Gaucher's disease and cancer: a sphingolipid perspective". Critical Reviews in Oncogenesis. 18 (3): 221–234. doi:10.1615/critrevoncog.2013005814. PMC 3604879. PMID 23510065.

Pandey MK, Burrow TA, Rani R, Martin LJ, Witte D, Setchell KD, et al. (March 2017). "Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease". Nature. 543 (7643): 108–112. doi:10.1038/nature21368. PMID 28225753. S2CID 4040507.

Christie WW (10 January 2019). "Lactosylceramide and non-Acidic Oligoglycosylceramides". The LipidHome. Archived from the original on 9 August 2016. Retrieved 13 July 2019.